Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Measure Twice, Cut Once | Main | So What's A Worthwhile Problem, Anyway? »

May 3, 2002

The Nuts and Bolts of a New Idea

Email This Entry

Posted by Derek

Well, Monday will mark the first test of the research ideas that I've been talking about (see the 4/28 and 5/2 posts below.) It's not the perfect experiment that I'd like, partly because it'll be testing one of the less-likely forms of the idea. On the flip side, if this one works, plenty of other stuff probably will, too. I have the starting materials I need ready to go, as well, which comes under the "bird in the hand" principle.

The main uncertainty is still in the control experiments. There's a way that I could get a false positive in this experiment, and there's no way to keep that from happening. It's intrinsic. But there is a way to control for it, leaving out one key factor in a separate experiment. If that run gives me the same result as the "real" one, then I'm in trouble. It'll mean that what looks like a positive result could just be what would happen anyway. I've got several "Plan B"s to go to at that point, other experiments with different starting materials that still might show that the underlying idea could work (just not on the first thing I tried.)

If the results are different in the control versus the real experiment, though, it'll be time to break out the party hats. But I won't know that for a while yet, unfortunately. The complicated part is that I can use a fairly straightforward method to measure how things are going, but it'll only work for the real experiment, not the control. There's a more complex method that'll work for both, so that's what I'll need to do the key head-to-head comparison. It won't be ready for prime time for another week or two; I have some colleagues who are going to work on that for me.

So, Monday's experiment is just a first hurdle. Using the straightforward readout, if the real experiment shows something, that's a necessary (but not sufficient!) piece of evidence. I'll be relieved, but I won't be high-fiving anyone. If it doesn't show anything, though, I'll know to move immediately on to one of those Plan Bs I mentioned.

One of those doesn't deserve that label, actually - it's the system that I think has the best chance of all of them of showing the effect I want. But it requires some chemical synthesis, which is in progress. With any luck, I'll have the necessary compounds made at about the same time my friends in the other hallway get the robust method for comparing the experimental results. When we get that all working at the same time, we'll be ready for some serious moments of truth. Monday's, by comparison, will be a small one. But I'm excited, just the same.

Comments (0) + TrackBacks (0) | Category: Birth of an Idea


COMMENTS

EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings